Active, not recruitingPhase 1NCT02989636

Nivolumab With or Without Stereotactic Radiosurgery in Treating Patients With Recurrent, Advanced, or Metastatic Chordoma

Studying Chordoma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Principal Investigator
Lawrence Kleinberg, MD
Johns Hopkins University/Sidney Kimmel Cancer Center
Intervention
Laboratory Biomarker Analysis(other)
Enrollment
21 enrolled
Eligibility
15 years · All sexes
Timeline
20172026

Study locations (2)

Collaborators

National Cancer Institute (NCI) · Bristol-Myers Squibb · Chordoma Foundation

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02989636 on ClinicalTrials.gov

Other trials for Chordoma

Additional recruiting or active studies for the same condition.

See all trials for Chordoma

← Back to all trials